Pharmaceuticals in the United Kingdom (UK) - Market Summary, Competitive Analysis and Forecast, 2016-2025

July 2021 | 52 pages | ID: P4338F859DBCEN
MarketLine

Abstracts

Pharmaceuticals in the United Kingdom (UK) - Market @Summary, Competitive Analysis and Forecast, 2016-2025

SUMMARY

Pharmaceuticals in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS

• The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
• The UK pharmaceuticals market had total revenues of $29.4bn in 2020, representing a compound annual growth rate (CAGR) of 4% between 2016 and 2020.
• As the government has attempted to reduce the state burden of healthcare, a number of changes to the market have been introduced, placing more of the workload in the hands of the private sector.
• Demographic factors, such as an ageing population and a growing obesity rate, are likely to drive demand for pharmaceutical products due to an increase in associated diseases such as diabetes and cardiovascular problems.

SCOPE

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the United Kingdom
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United Kingdom
• Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom pharmaceuticals market with five year forecasts

REASONS TO BUY

• What was the size of the United Kingdom pharmaceuticals market by value in 2020?
• What will be the size of the United Kingdom pharmaceuticals market in 2025?
• What factors are affecting the strength of competition in the United Kingdom pharmaceuticals market?
• How has the market performed over the last five years?
• Who are the top competitors in the United Kingdom's pharmaceuticals market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths of leading players?
7.4. What strategies do leading players follow?
7.5. Are there any threats towards leading players?

8 COMPANY PROFILES

8.1. Novartis AG
8.2. GlaxoSmithKline Plc
8.3. AstraZeneca PLC
8.4. Pfizer Inc.

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: United Kingdom pharmaceuticals market value: $ billion, 2016-20
Table 2: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: United Kingdom pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: United Kingdom pharmaceuticals market share: % share, by value, 2020
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Key Employees
Table 8: Novartis AG: Key Employees Continued
Table 9: GlaxoSmithKline Plc: key facts
Table 10: GlaxoSmithKline Plc: Annual Financial Ratios
Table 11: GlaxoSmithKline Plc: Annual Financial Ratios (Continued)
Table 12: GlaxoSmithKline Plc: Key Employees
Table 13: GlaxoSmithKline Plc: Key Employees Continued
Table 14: AstraZeneca PLC: key facts
Table 15: AstraZeneca PLC: Annual Financial Ratios
Table 16: AstraZeneca PLC: Key Employees
Table 17: Pfizer Inc.: key facts
Table 18: Pfizer Inc.: Annual Financial Ratios
Table 19: Pfizer Inc.: Key Employees
Table 20: Pfizer Inc.: Key Employees Continued
Table 21: United Kingdom size of population (million), 2016-20
Table 22: United Kingdom gdp (constant 2005 prices, $ billion), 2016-20
Table 23: United Kingdom gdp (current prices, $ billion), 2016-20
Table 24: United Kingdom inflation, 2016-20
Table 25: United Kingdom consumer price index (absolute), 2016-20
Table 26: United Kingdom exchange rate, 2016-20

List Of Figures

LIST OF FIGURES

Figure 1: United Kingdom pharmaceuticals market value: $ billion, 2016-20
Figure 2: United Kingdom pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: United Kingdom pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in the United Kingdom, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in the United Kingdom, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in the United Kingdom, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United Kingdom, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the United Kingdom, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the United Kingdom, 2020
Figure 10: United Kingdom pharmaceuticals market share: % share, by value, 2020